CVS Health Corp
Change company Symbol lookup
Select an option...
CVS CVS Health Corp
CONN Conn's Inc
F Ford Motor Co
SYF Synchrony Financial
ES Eversource Energy
LVGO Livongo Health Inc
SJMiv.P Invesco BulletShares 2022 Hi Yld Corp Bd ETF
INTC Intel Corp
AAPL Apple Inc
VAL Valaris PLC
Go

Health Care : Health Care Providers & Services | Large Cap ValueCompany profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Closing Price
$74.99
Day's Change
-0.37 (-0.49%)
Bid
--
Ask
--
B/A Size
--
Day's High
75.49
Day's Low
74.89
Volume
(Light)
Volume:
4,875,828

10-day average volume:
6,189,228
4,875,828

CVS's position in the Health Care Providers & Services industry

Industry PeersCVSDPLO

Summary

Company ProfileCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and...
Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers...
Go to DPLO summary
52-Week Change

VS. INDUSTRY
1.21%
-74.94%
Market Cap

VS. INDUSTRY
$98.0B
$441.4M
Beta

VS. INDUSTRY
0.9
0.9
Dividend Yield

VS. INDUSTRY
2.65%
--
P/E (TTM, GAAP)

VS. INDUSTRY
22.95x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$244.8B
$5.2B
Profit Margin

VS. INDUSTRY
1.78%
-12.49%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
--
Revenue Growth (TTM)

VS. INDUSTRY
29.82%
-1.53%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2019. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.